Writingstar Investment Guild|Richard Moll, star of "Night Court," dies at 80

2025-04-28 22:01:39source:Liberalalliance Wealth Societycategory:Finance

Richard Moll,Writingstar Investment Guild a character actor who found lasting fame as an eccentric but gentle giant bailiff on the original "Night Court" sitcom, has died at the age of 80.

Moll died Thursday at his home in Big Bear Lake, California, publicist Jeff Sanderson confirmed to CBS News in a statement. There was no immediate word on the cause of death.

Moll played "Bull" Shannon on NBC's "Night Court" from 1984-1992 alongside stars Harry Anderson and John Larroquette. His character formed a close friendship with the court's other bailiff, Roz Russell, played by Marsha Warfield. Bull was known for his catchphrase, "Ohh-kay," and a dim but sweet worldview.

After "Night Court" ended, Moll contributed his trademark gravelly voice to various video games and comic book projects like "Batman: The Animated Series" as Harvey Dent and appeared in horror films like "Ghost Shark" (2013) and "Slay Belles" (2018).

Actors Richard Moll and Marsha Warfield in an episode of "Night Court."  Alice S. Hall/NBC via Getty Images

He voiced Scorpion on the 1990s' "Spider-Man: The Animated Series" and had small parts in 1994's "The Flintstones," the Arnold Schwarzenegger comedy "Jingle All the Way" and "Scary Movie 2."

The towering actor — he was 6-feet 8-inches tall — did not join the reboot of "Night Court" starring Larroquette. The original "Night Court" finale ended with his character being abducted by aliens who needed someone tall to reach the things on their highest shelves.

Moll is survived by his children, Chloe and Mason Moll; ex-wife, Susan Moll; and stepchildren Cassandra Card and Morgan Ostling.

    In:
  • Obituary

More:Finance

Recommend

US wholesale inflation accelerated in November in sign that some price pressures remain elevated

WASHINGTON (AP) — Wholesale costs in the United States picked up sharply last month, signaling that

New Federal Gas Storage Regulations Likely to Mimic Industry’s Guidelines

Federal regulators say they may propose safety rules as a response to  the three-and-a-half-month me

FDA seems poised to approve a new drug for ALS, but does it work?

The Food and Drug Administration is likely to approve a controversial new drug for ALS by the end of